Literature DB >> 20012309

Prevalence of MS in Iranian immigrants to British Columbia, Canada.

Colleen Guimond, David A Dyment, Sreeram V Ramagopalan, Gavin Giovannoni, Maria Criscuoli, Irene M Yee, George C Ebers, A Dessa Sadovnick.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 20012309     DOI： 10.1007/s00415-009-5417-7

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  10 in total

Review 1.  Multiple sclerosis.

Authors:  J H Noseworthy; C Lucchinetti; M Rodriguez; B G Weinshenker
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

Review 2.  The worldwide prevalence of multiple sclerosis.

Authors:  Maura Pugliatti; Stefano Sotgiu; Giulio Rosati
Journal:  Clin Neurol Neurosurg       Date:  2002-07       Impact factor: 1.876

3.  Cigarette smoking and the progression of multiple sclerosis.

Authors:  Miguel A Hernán; Susan S Jick; Giancarlo Logroscino; Michael J Olek; Alberto Ascherio; Hershel Jick
Journal:  Brain       Date:  2005-03-09       Impact factor: 13.501

Review 4.  Environmental factors and multiple sclerosis.

Authors:  George C Ebers
Journal:  Lancet Neurol       Date:  2008-03       Impact factor: 44.182

5.  Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis.

Authors:  Kassandra L Munger; Lynn I Levin; Bruce W Hollis; Noel S Howard; Alberto Ascherio
Journal:  JAMA       Date:  2006-12-20       Impact factor: 56.272

6.  Canadian collaborative project on genetic susceptibility to MS, phase 2: rationale and method. Canadian Collaborative Study Group.

Authors:  A D Sadovnick; N J Risch; G C Ebers
Journal:  Can J Neurol Sci       Date:  1998-08       Impact factor: 2.104

7.  Regional variation of multiple sclerosis prevalence in Canada.

Authors:  Cynthia A Beck; Luanne M Metz; Lawrence W Svenson; Scott B Patten
Journal:  Mult Scler       Date:  2005-10       Impact factor: 6.312

8.  Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.

Authors:  Lynn I Levin; Kassandra L Munger; Mark V Rubertone; Charles A Peck; Evelyne T Lennette; Donna Spiegelman; Alberto Ascherio
Journal:  JAMA       Date:  2005-05-25       Impact factor: 56.272

9.  Multiple sclerosis in Isfahan, Iran.

Authors:  Mohammad Saadatnia; Masoud Etemadifar; Amir Hadi Maghzi
Journal:  Int Rev Neurobiol       Date:  2007       Impact factor: 3.230

10.  Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway.

Authors:  Catherine Smestad; Leiv Sandvik; Trygve Holmoy; Hanne Flinstad Harbo; Elisabeth Gulawson Celius
Journal:  J Neurol       Date:  2007-12-20       Impact factor: 4.849
  10 in total
  4 in total

Review 1.  Prevalence of multiple sclerosis in Iranian emigrants: review of the evidence.

Authors:  Zahra Nasr; Masoud Majed; Abdolmohamad Rostami; Mohamad Ali Sahraian; Alireza Minagar; Arman Amini; Jeanine C McGee; Masoud Etemadifar
Journal:  Neurol Sci       Date:  2016-06-28       Impact factor: 3.307

2.  Epidemiology of multiple sclerosis in Iran: A systematic review and meta-analysis.

Authors:  Milad Azami; Mohammad Hossein YektaKooshali; Masoumeh Shohani; Ali Khorshidi; Leily Mahmudi
Journal:  PLoS One       Date:  2019-04-09       Impact factor: 3.240

Review 3.  Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms.

Authors:  Cullen O'Gorman; Robyn Lucas; Bruce Taylor
Journal:  Int J Mol Sci       Date:  2012-09-18       Impact factor: 6.208

Review 4.  The Nerves to Conduct a Multiple Sclerosis Crime Investigation.

Authors:  Sameeksha Chopra; Zoë Myers; Henna Sekhon; Antoine Dufour
Journal:  Int J Mol Sci       Date:  2021-03-02       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.